The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization
- PMID: 30819478
- DOI: 10.1016/j.jvir.2018.10.002
The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization
Abstract
Purpose: To evaluate efficacy of cone-beam CT-based liver perfusion mapping obtained immediately following conventional transarterial chemoembolization of hepatocellular carcinoma (HCC) for assessing tumor vascularity, technical success of chemoembolization, and treatment response.
Materials and methods: From July 2015 to June 2016, 35 patients with 57 HCCs who underwent cone-beam CT with post-processing software via conventional transarterial chemoembolization for HCC and follow-up examination were included. Three reviewers evaluated technical success on angiography, unenhanced cone-beam CT, contrast-enhanced cone-beam CT, and cone-beam CT-based liver perfusion mapping after transarterial chemoembolization per tumor and per patient. Parenchymal blood volume (PBV) was measured. Treatment response was determined on follow-up CT, MR imaging, or histopathology according to modified Response Evaluation Criteria In Solid Tumors. Diagnostic performance for detection of a viable tumor was evaluated using multiple logistic regression with C-statistics.
Results: Treatment response was 38, 17, 2, and 0 for complete response, partial response, stable disease, and progressive disease per tumor and 18, 15, 2, and 0 per patient. In multiple logistic regression, unenhanced cone-beam CT, contrast-enhanced cone-beam CT, cone-beam CT-based liver perfusion mapping, mean value of PBV, and maximum value of PBV of tumor were significant in response assessment for per tumor and per patient (per tumor, all P < .001; per patient, P = .015, P = .001, P < .001, P = .020, and P = .032). Mean value of PBV of tumor was excellent for evaluating technical success with the highest C-statistic (0.880 and 0.920 for per tumor and per patient), followed by that of visual assessment of cone-beam CT-based liver perfusion mapping (0.864 and 0.908).
Conclusions: Cone-beam CT-based liver perfusion mapping provided reliable images to evaluate technical success after transarterial chemoembolization of HCC by qualitative visual assessment and quantitative perfusion values.
Copyright © 2018 SIR. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?J Vasc Interv Radiol. 2019 Mar;30(3):380-389.e4. doi: 10.1016/j.jvir.2018.09.001. J Vasc Interv Radiol. 2019. PMID: 30819480
-
Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response.J Vasc Interv Radiol. 2013 Apr;24(4):483-9. doi: 10.1016/j.jvir.2013.01.001. Epub 2013 Feb 26. J Vasc Interv Radiol. 2013. PMID: 23452553
-
Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.Anticancer Res. 2017 Oct;37(10):5681-5685. doi: 10.21873/anticanres.12004. Anticancer Res. 2017. PMID: 28982886
-
The Role of Cone-Beam CT in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.J Vasc Interv Radiol. 2017 Mar;28(3):334-341. doi: 10.1016/j.jvir.2016.11.037. Epub 2017 Jan 18. J Vasc Interv Radiol. 2017. PMID: 28109724
-
Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.World J Gastroenterol. 2016 May 28;22(20):4835-47. doi: 10.3748/wjg.v22.i20.4835. World J Gastroenterol. 2016. PMID: 27239110 Free PMC article. Review.
Cited by
-
Role of Cone-Beam CT in the Intraprocedural Evaluation of Chemoembolization of Hepatocellular Carcinoma.J Oncol. 2021 Mar 19;2021:8856998. doi: 10.1155/2021/8856998. eCollection 2021. J Oncol. 2021. PMID: 33790970 Free PMC article.
-
The value of intra-procedural transcatheter intraarterial contrast-enhanced ultrasonography (IA-CEUS) in predicting the short-term efficacy of conventional transarterial chemoembolization (cTACE).Transl Cancer Res. 2020 May;9(5):3600-3609. doi: 10.21037/tcr.2020.04.17. Transl Cancer Res. 2020. PMID: 35117723 Free PMC article.
-
Baseline parenchymal blood volume is a potential prognostic imaging biomarker in patients with malignant liver tumors treated with transarterial chemoembolization.Abdom Radiol (NY). 2024 Sep;49(9):3056-3068. doi: 10.1007/s00261-024-04240-9. Epub 2024 Apr 20. Abdom Radiol (NY). 2024. PMID: 38642095 Free PMC article.
-
Model-based perfusion reconstruction with time separation technique in cone-beam CT dynamic liver perfusion imaging.Med Phys. 2025 Apr;52(4):2074-2088. doi: 10.1002/mp.17652. Epub 2025 Jan 27. Med Phys. 2025. PMID: 39871400 Free PMC article.
-
Cone Beam Computed Tomography for the Interventional Oncologist: A Practical Approach.Semin Intervent Radiol. 2024 Aug 19;41(3):252-257. doi: 10.1055/s-0044-1788006. eCollection 2024 Jun. Semin Intervent Radiol. 2024. PMID: 39165650 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical